voriconazole + anidulafungin
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Aspergillosis
Conditions
Aspergillosis
Trial Timeline
Aug 1, 2008 → Feb 1, 2009
NCT ID
NCT00620074About voriconazole + anidulafungin
voriconazole + anidulafungin is a approved stage product being developed by Pfizer for Aspergillosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00620074. Target conditions include Aspergillosis.
What happened to similar drugs?
7 of 15 similar drugs in Aspergillosis were approved
Approved (7) Terminated (5) Active (6)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00620074 | Approved | Terminated |
Competing Products
20 competing products in Aspergillosis